Nuclear Radiology: Page 22

CZT-based SPECT MPI may predict cardiac outcomes

By Wayne Forrest

SPECT gamma cameras featuring cadmium zinc telluride-based (CZT) digital detector technology are just what the nuclear cardiologist ordered to diagnose seemingly healthy patients with cardiac symptoms and to help predict their chances for an adverse event, according to a study published online April 27 in the Journal of Nuclear Medicine.

May 8, 2017

Lantheus, GE finalize license agreement

By AuntMinnie.com staff writers

Lantheus Medical Imaging has signed a definitive agreement with GE Healthcare to support the worldwide development and commercialization of its flurpiridaz F-18 investigational PET radiopharmaceutical. The firms are also continuing their current supply agreement for other nuclear medicine products.

April 24, 2017

Immuno-PET radiotracers may aid cancer treatment

By AuntMinnie.com staff writers

Researchers at Stanford University are assessing how well new PET radiopharmaceuticals, called immuno-PET tracers, can accurately identify molecules in cancer cells that prevent the immune system from attacking the disease, according to a study published in the April issue of the Journal of Nuclear Medicine.

April 6, 2017

SNMMI offers appropriate use criteria for 2 cancers

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria for bone scintigraphy in patients with prostate or breast cancer.

April 6, 2017

IBA Molecular forms Curium as new radiopharmacy player

By Erik L. Ridley

Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt Nuclear Medicine to form Curium, a new company with a mission to be a global developer, manufacturer, and supplier of SPECT, PET, and therapeutic radiopharmaceuticals.

April 5, 2017

PET identifies cell mutations in NSCLC patients

By AuntMinnie.com staff writers

With the help of FDG-PET and an advanced image analysis technique known as radiomics, researchers have identified genetic cell mutations that can cause non-small cell lung cancer (NSCLC), according to a study published in the April issue of the Journal of Nuclear Medicine.

April 3, 2017

Novel PET tracer aids recurrent prostate cancer patients

By Wayne Forrest

A study in the March issue of the Journal of Nuclear Medicine is touting the PET radiotracer fluciclovine F-18 for its ability to guide and monitor targeted treatment for recurrent prostate cancer.

March 7, 2017

New PET tracer shows promise for atherosclerosis

By AuntMinnie.com staff writers

European researchers have developed a PET tracer that has shown the ability to quickly and noninvasively identify life-threatening atherosclerotic plaques, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 1, 2017

New PET tracer advances prostate cancer detection

By AuntMinnie.com staff writers

Researchers have developed a new PET radiotracer designed to detect both early and advanced prostate cancer and help direct treatment, according to a study in the February issue of the Journal of Nuclear Medicine.

January 31, 2017

Chinese nuclear medicine firm comes to U.S.

By AuntMinnie.com staff writers

Chinese nuclear medicine equipment developer Top Grade Healthcare is setting down roots in the U.S.

January 11, 2017

Journal of Nuclear Medicine gets new editor in chief

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging has tapped Dr. Johannes Czernin to be the new editor in chief of the Journal of Nuclear Medicine.

January 3, 2017

Is the U.S. due for a shortage of SPECT tracers? Part 2

By Giananthony Rizzo

In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.

November 17, 2016

Previous Page

Page 22 of 81

Next Page